Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$349,571,550
-$90,579,781 QoQ
Shares Held
14,517,091
-7.4% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#44
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. PFE ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,571,550 | 14,517,091 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $440,151,331 | 15,674,905 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $310,613,854 | 12,474,452 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $306,869,245 | 12,043,534 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $272,759,121 | 11,252,439 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $547,736,668 | 21,615,496 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $500,684,479 | 18,872,389 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $606,495,348 | 20,956,992 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $478,232,788 | 17,091,951 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $697,634,139 | 25,139,969 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $879,363,400 | 30,544,057 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,625,817,000 | 49,014,682 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,195,643,177 | 32,596,597 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,509,519,705 | 36,998,032 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,838,109,000 | 35,872,541 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,595,839,198 | 36,467,989 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,831,810,350 | 34,938,210 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,829,709,646 | 35,343,049 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,554,427,179 | 43,258,716 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,685,700,134 | 39,193,214 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $951,386,208 | 24,294,847 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $842,997,611 | 23,267,944 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,161,428,604 | 31,551,986 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,458,500,160 | 39,741,188 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,554,445,287 | 47,536,504 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,660,139,861 | 50,862,197 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||